4D Molecular Therapeutics Inc - FDMT - stock price prediction, stock price target, analyst ratings from 11 analysts

4D Molecular Therapeutics Inc has a share price target of US$ 28, revenue growth forecast of -86.4%, and profit growth estimate of -97.4% for FY26, based on top 11 analyst calls.